[The dissolving capacity of secreted bile during cholestyramine medication for human gallstones and artificially produced cholesterol concrements].
D001646:Bile / Q000032:analysis; D001647:Bile Acids and Salts / Q000494:pharmacology*; D002137:Calculi / Q000139:chemically induced / Q000188:drug therapy; D002769:Cholelithiasis / Q000188:drug therapy*; D002784:Cholesterol / Q000009:adverse effects / Q000032:analysis; D002792:Cholestyramine Resin / Q000627:therapeutic use*; D006801:Humans; D012995:Solubility; D012997:Solvents / Q000494:pharmacology
D001647:Bile Acids and Salts; D012997:Solvents; D002792:Cholestyramine Resin; D002784:Cholesterol
Das Lösungsvermögen der während Cholestyramimmedikatin sezernierten Galle für menschliche Gallensteine und aus reinem Cholesterin hergestellte Konkremente.